πŸ‡ΊπŸ‡Έ FDA
Patent

US 9718811

(S)-enantiomer of mepazine

granted A61KA61K31/5415A61P

Quick answer

US patent 9718811 ((S)-enantiomer of mepazine) held by Ludwig-Maximilians-Universitat Munchen expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ludwig-Maximilians-Universitat Munchen
Grant date
Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/5415, A61P, A61P35/00